$3.20 -0.10 (-3.03%)
2/10/2012 4:00 PM

Keryx Biopharmaceuticals (NASDAQ:KERX)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Featured Broker Partners


Advertisement